Friday, June 13
14.00-17.00  Red Hall 1

> Welcome
H. Haller (Hannover, Germany)

> Treatment of hypertensive patients is more than blood-pressure control
S. MacMahon (Sydney, Australia)

> Optimal antihypertensive treatment to maximise patient benefit
G. Mancia (Monza, Italy)

> The patient’s benefit with low-dose acetylsalicylic acid treatment
R. De Caterina (Chieti, Italy)

> Renal vasculature as a therapeutic target for the prevention of chronic renal disease
J. Radermacher (Hannover, Germany)

> Evidence based medicine paves the way for treating hypertensive diabetics with CCB’s
L.M. Ruilope (Madrid, Spain)

> Acarbose reduces cardiovascular risk in patients with dysglycaemia: clinical evidence from
   STOP-NIDDM
R.G. Josse (Toronto, Canada)

> The endothelium – central target of risk factors
H. Haller (Hannover, Germany)

> Panel discussion on vascular protection

> Conclusion